SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0001104659-23-052736
Filing Date
2023-04-28
Accepted
2023-04-28 14:47:45
Documents
28

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 2309361
2 filename2.htm EX-3.1 597562
3 filename3.htm EX-21.1 2155
4 GRAPHIC bc_adbry-4c.jpg GRAPHIC 52648
5 GRAPHIC bc_amlitelimab-4c.jpg GRAPHIC 53011
6 GRAPHIC bc_dupixent-4c.jpg GRAPHIC 53881
7 GRAPHIC bc_indication-4c.jpg GRAPHIC 151534
8 GRAPHIC bc_nhphalf-4c.jpg GRAPHIC 101329
9 GRAPHIC bc_proportion-4c.jpg GRAPHIC 191157
10 GRAPHIC bc_responders-4c.jpg GRAPHIC 58056
11 GRAPHIC bc_siggle-4c.jpg GRAPHIC 248181
12 GRAPHIC fc_antigen-4c.jpg GRAPHIC 831159
13 GRAPHIC fc_disrupted-4c.jpg GRAPHIC 490358
14 GRAPHIC fc_signaling-4c.jpg GRAPHIC 483631
15 GRAPHIC fc_untreated-4c.jpg GRAPHIC 951569
16 GRAPHIC lc_affinity-4c.jpg GRAPHIC 661798
17 GRAPHIC lc_humanhalf-4c.jpg GRAPHIC 87111
18 GRAPHIC lc_humanhalflife-4c.jpg GRAPHIC 204524
19 GRAPHIC lc_inhibition-4c.jpg GRAPHIC 153693
20 GRAPHIC lc_mrnaexpression-4c.jpg GRAPHIC 150678
21 GRAPHIC lc_nhppkadministration-4c.jpg GRAPHIC 242738
22 GRAPHIC lc_normalized-4c.jpg GRAPHIC 156968
23 GRAPHIC lg_apogeetherapeutics-4c.jpg GRAPHIC 131108
24 GRAPHIC pht_apogee-4c.jpg GRAPHIC 704535
25 GRAPHIC pht_eczemaarea-4c.jpg GRAPHIC 390537
26 GRAPHIC pht_human-4c.jpg GRAPHIC 446294
27 GRAPHIC tbl_apogeetarget-4c.jpg GRAPHIC 334367
28 GRAPHIC tbl_morphological-4c.jpg GRAPHIC 286189
  Complete submission text file 0001104659-23-052736.txt   12762407
Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, LLC (Filer) CIK: 0001974640 (see all company filings)

IRS No.: 880588063 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-06691 | Film No.: 23864608
SIC: 2836 Biological Products, (No Diagnostic Substances)